Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy

BACKGROUND: The systemic administration of cytotoxic chemotherapeutic agents for cancer treatment often has toxic side effects, limiting the usage dose. To increase chemotherapeutic efficacy while reducing toxic effects, a rational design for synergy-based drug regimens is essential. This study inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Alemi, Ashraf, Zavar Reza, Javad, Haghiralsadat, Fateme, Zarei Jaliani, Hossein, Haghi Karamallah, Mojtaba, Hosseini, Seyed Ahmad, Haghi Karamallah, Somayeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865280/
https://www.ncbi.nlm.nih.gov/pubmed/29571289
http://dx.doi.org/10.1186/s12951-018-0351-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865280/
https://www.ncbi.nlm.nih.gov/pubmed/29571289
http://dx.doi.org/10.1186/s12951-018-0351-4

Ejemplares similares